Table 1 Baseline characteristics of the overall population and by groups.
Overall | (%) | CBOT | (%) | ProGlide | (%) | P | |
---|---|---|---|---|---|---|---|
229 | (100%) | 135 | (59%) | 94 | (41%) | ||
Age (year) | 81.8 | ± 5.7 | 81.8 | ± 5.8 | 81.8 | ± 5.6 | 0.927 |
Female | 121 | (52.8) | 75 | (55.6) | 46 | (48.9) | 0.324 |
Arterial Hypertension | 200 | (87.3) | 121 | (89.6) | 79 | (84.0) | 0.211 |
Active Smoker | 19 | (8.3) | 11 | (8.1) | 8 | (8.5) | 0.922 |
DM | 77 | (33.6) | 44 | (32.6) | 33 | (35.1) | 0.692 |
AF | 76 | (33.2) | 43 | (31.9) | 33 | (35.1) | 0.607 |
COPD | 58 | (35.3) | 30 | (22.2) | 28 | (29.8) | 0.195 |
Prior Cardiac revascularization | 46 | (20.1) | 22 | (16.3) | 24 | (25.5) | 0.086 |
Prior AMI | 22 | (9.6) | 10 | (7.4) | 12 | (12.8) | 0.176 |
Prior PCI | 40 | (17.5) | 19 | (14.1) | 21 | (22.3) | 0.105 |
Prior CABG | 16 | (7.0) | 8 | (5.9) | 8 | (8.5) | 0.450 |
Prior TAVR | 1 | (0.4) | 1 | (0.7) | 0 | (0.0) | 0.403 |
Prior SAVR | 6 | (2.6) | 5 | (3.7) | 1 | (1.1) | 0.219 |
PAD | 28 | (12.2) | 14 | (10.4) | 14 | (14.9) | 0.304 |
Hb (g/dL) | 12.1 | ± 1.7 | 12.2 | ± 1.6 | 11.9 | ± 1.8 | 0.213 |
Cr (mg/dL) | 1.3 | ± 1.3 | 1.3 | ± 1.3 | 1.3 | ± 1.1 | 0.683 |
EF (%) | 55.7 | ± 10.8 | 56.0 | ± 9.9 | 54.5 | ± 14.1 | 0.479 |
Aortic Mean Gradient (mmHg) | 47.1 | ± 14.4 | 47.7 | ± 14.1 | 44.3 | ± 15.4 | 0.259 |
Beta-blocker | 140/228 | (61.4) | 79 | (59) | 61 | (64.9) | 0.365 |
OAC | 77 | (33.6) | 41 | (30.4) | 36 | (38.3) | 0.212 |
ASA | 140 | (61.1) | 82 | (60.7) | 58 | (61.7) | 0.883 |
Clopidogrel | 42 | (18.3) | 20 | (14.8) | 22 | (23.4) | 0.098 |
Ticagrelor | 3 | (1.3) | 1 | (0.7) | 2 | (2.1) | 0.364 |
DAPT | 26 | (11.4) | 11 | (8.1) | 15 | (16) | 0.067 |